Belpointe Asset Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $226K | Buy |
8,208
+15
| +0.2% | +$414 | 0.01% | 841 |
|
|
2025
Q1 | $232K | Buy |
+8,193
| New | +$232K | 0.01% | 802 |
|
|
2024
Q4 | – | Sell |
-6,927
| Closed | -$463K | – | 922 |
|
|
2024
Q3 | $463K | Buy |
6,927
+4,865
| +236% | +$325K | 0.03% | 521 |
|
|
2024
Q2 | $245K | Sell |
2,062
-15,790
| -88% | -$1.88M | 0.02% | 658 |
|
|
2024
Q1 | $1.9M | Buy |
17,852
+2,587
| +17% | +$276K | 0.14% | 135 |
|
|
2023
Q4 | $1.52M | Buy |
15,265
+7,685
| +101% | +$764K | 0.13% | 155 |
|
|
2023
Q3 | $783K | Buy |
7,580
+5,346
| +239% | +$552K | 0.08% | 242 |
|
|
2023
Q2 | $271K | Sell |
2,234
-24,693
| -92% | -$3M | 0.03% | 490 |
|
|
2023
Q1 | $4.14M | Sell |
26,927
-4,417
| -14% | -$678K | 0.22% | 82 |
|
|
2022
Q4 | $5.63M | Buy |
31,344
+12,434
| +66% | +$2.23M | 0.34% | 50 |
|
|
2022
Q3 | $2.24M | Buy |
18,910
+13,928
| +280% | +$1.65M | 0.15% | 132 |
|
|
2022
Q2 | $711K | Sell |
4,982
-510
| -9% | -$72.8K | 0.05% | 379 |
|
|
2022
Q1 | $946K | Buy |
5,492
+328
| +6% | +$56.5K | 0.06% | 354 |
|
|
2021
Q4 | $1.31M | Sell |
5,164
-908
| -15% | -$231K | 0.08% | 247 |
|
|
2021
Q3 | $2.34M | Sell |
6,072
-1,580
| -21% | -$608K | 0.16% | 134 |
|
|
2021
Q2 | $1.8M | Buy |
7,652
+2,418
| +46% | +$568K | 0.13% | 170 |
|
|
2021
Q1 | $685K | Sell |
5,234
-877
| -14% | -$115K | 0.06% | 333 |
|
|
2020
Q4 | $639K | Buy |
6,111
+294
| +5% | +$30.7K | 0.06% | 343 |
|
|
2020
Q3 | $411K | Sell |
5,817
-2,027
| -26% | -$143K | 0.05% | 366 |
|
|
2020
Q2 | $504K | Buy |
+7,844
| New | +$504K | 0.07% | 304 |
|